With a focus on rare and orphan diseases and a heritage in digital, we deliver communication programmes that reach and engage people at the right time through the right channels.
We work for clients at a project level via apps, websites, meetings and written material and at a full scale programme level where we design, brand, implement and measure complex multichannel programmes. And because the entire development lifecycle within Pharma now embraces multichannel communications our clients typically include clinical, medical affairs and marketing departments.
How does this benefit our pharma clients?
Our communications, campaigns and digital assets are inherently on target because they were created by the end users themselves, in a language they understand be they patients, relatives, physicians and other members of the healthcare team.
You can only really understand your customers by becoming immersed in their worlds. Through co-creation and in depth interviews we identify the unique unmet needs of physicians and patients and design communications around these.
Patient & KOL mapping | Patient & KOL focus groups | Ethnography | Video storytelling | Behavioural insights
With our previous senior level experience within Pharma companies we understand your pain points when you deliver a project or campaign at multiple points along lifecycle planning. We partner with you and your customers be they health care professionals or patients and advocacy groups to design and deliver targeted, measurable communications.
Clinical trial co-design | Multichannel strategy | Web & App design/development | Patient engagement | Digital transformation
We are immersed in the rare disease world and continually seek to gather and disseminate information to our clients through our blogs, videos and attendance at conferences. We engage with a large network of rare disease advocates and physicians across Europe and we work with them to drive awareness and outreach campaigns on your behalf.
Patient activation campaigns | Digital solutions for patients & physicians | Conference support | Outreach & engagement with patients, patient advisory groups & physicians
We are proud to deliver the not for profit Rare Disease video Series which captures stories from people affected with rare conditions, their families and those who treat them. We believe that working for not-for-profit clients allows us to give something back, to think in different ways and try new ways of engaging with audiences.
Our patient partner programme is at the heart of what we do and is proven to create understanding and trust between patients and Life Science industries. Our unique programme recruits and coaches patient partners for our clients in the rare disease space allowing us to co-create branded and unbranded assets in digital, face to face and print channels. This allows us to create award winning multichannel programmes for our clients. Swii.ch facilitates the co-creation process providing training and mentoring for patients and organisations otherwise not used to working with pharma. We believe this sets us apart as the only rare disease digital communications agency in Europe.
How does this benefit our pharma clients?
We recognise the unique challenges for rare disease life science companies can be identification and sourcing of people impacted by these conditions. This is even before the challenges of insight gathering and co-creation begin. We build our extensive network by providing support to our patient partners by coaching and mentoring. This can take the form of social media training, film and media skills along with an understanding of the regulatory requirements of pharma.
Since 2015 we have been creating solutions for a number of forward thinking pharma companies. Our work is based on an understanding of the unique challenges companies face when working in the rare disease space. Be it disease recognition amongst physicians, shortening the time to diagnosis, patient identification and engagement, digital support and fostering advocacy. We have worked with clients to develop solutions from clinical trial, planning and recruitment through to launch.
Sorry, no posts matched your criteria.
“I had the pleasure of working with Rachel and Rob at a recent global medical meeting this year. Rachel and Rob were instrumental in the development and coordination of a very innovative, patient focussed session there. Through their complementary experience and expertise, they were able to engage the audience fully from the start and involve them in a patient journey mapping exercise”
“Overall, the session received the highest rating in terms of feedback for the entire meeting. I highly recommend others within the pharmaceutical industry cross-functionally, to benefit from their approach in the development of similar projects and events…”
Senior Global Medical Advisor & Voice of the Patient Lead
Our Directors and Consultants are unique in that they have 15 plus years as senior leaders within the Pharma industry and from leading digital and communications agencies.
You can be assured that you are in safe hands and uniquely, you will be working with our senior partners throughout the lifecycle of your project.
Rob has over 15 years experience working in digital communications. He founded the independent digital agency Elevator Digital which was acquired by Publicis Groupe. Rob has since held senior roles with Saatchi & Saatchi Health and Razorfish.
Rachel is a Pharmacist and behavioural scientist by background and has had a 15 year long career in a large Pharma company in Medical Affairs, Digital Innovation and Patient Affairs. She has worked as a Management Consultant across Europe and the US in areas of patient centricity and digital delivery.
Sheila Khawaja is an acromegaly patient since 2003 and the current Vice-Chair of the World Alliance of Pituitary Organizations (WAPO), a non-profit entity that unites the global international pituitary community.
She recently became a EURORDIS ExPress Summer School Fellow.
We love to keep up to date with the latest thinking in rare disease patient and healthcare professional engagement via digital channels. Have a read and see what you think.
A snapshot of the results from our recent patient insight workshop to uncover the truth behind search behaviour....
Here is a burning question – Why is it that despite the plethora of apps now available, some abandonment statistics suggest that 90% of health apps are deleted or n...